{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:46:30Z","timestamp":1793083590912,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["60-63600-98-911"],"award-info":[{"award-number":["60-63600-98-911"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Given the high prevalence of Cluster-C Personality Disorders (PDs) in clinical populations, disease burden, high societal costs and poor prognosis of comorbid disorders, a major gain in health care can be achieved if Cluster-C PDs are adequately treated. The only controlled cost-effectiveness study published so far found Individual Schema Therapy (IST) to be superior to Treatment as Usual (TAU). Group ST (GST) might improve cost-effectiveness as larger numbers can be treated in (&gt;50%) less time compared to IST. However, to date there is no RCT supporting its (cost-) effectiveness. The overall aim of this study is to assess the evidence for GST for Cluster-C PDs and to improve treatment allocation for individual patients. Three main questions are addressed: 1) Is GST for Cluster-C PDs (cost-)effective compared to TAU? 2) Is GST for Cluster-C PDs (cost-) effective compared to IST? 3) Which patient-characteristics predict better response to GST, IST, or TAU?<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a multicenter RCT, the treatment conditions GST, IST, and TAU are compared in 378 Cluster-C PD patients within 10 sites. GST and IST follow treatment protocols and are completed within 1 year. TAU is the optimal alternative treatment available at the site according to regular procedures. Severity of the Cluster-C PD is the primary outcome, assessed with clinical interviews by independent raters blind for treatment. Functioning and wellbeing are important secondary outcomes. Assessments take place at week 0 (baseline), 17 (mid-GST), 34 (post-GST), 51 (post-booster sessions of GST), and 2 years (FU). Patient characteristics predicting better response to a specific treatment are studied, e.g., childhood trauma, autistic features, and introversion. A tool supporting patients and clinicians in matching treatment to patient will be developed. An economic evaluation investigates the cost-effectiveness and cost-utility from a societal perspective. A process evaluation by qualitative methods explores experiences of participants, loved ones and therapists regarding recovery, quality of life, and improving treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study will determine the (cost-)effectiveness of treatments for Cluster-C PDs regarding treatment type as well as optimal matching of patient to treatment and deliver insight into which aspects help Cluster-C-PD patients recover and create a fulfilling life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Dutch Trial Register: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=NL9209\">NL9209<\/jats:ext-link>. Registered on 28-01-2021,<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-022-04248-9","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T22:02:39Z","timestamp":1665266559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Design of an RCT on cost-effectiveness of group schema therapy versus individual schema therapy for patients with Cluster-C personality disorder: the QUEST-CLC study protocol"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-4567","authenticated-orcid":false,"given":"Iuno Z.","family":"Groot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie S. M.","family":"Venhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-2692","authenticated-orcid":false,"given":"Nathan","family":"Bachrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Walhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bregje","family":"de Moor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Nikkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Dalmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrte","family":"Maarschalkerweerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl R.","family":"van Aalderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinde","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske","family":"Wichers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha Ph.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M. A. A.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul P. P. P.","family":"Grasman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud","family":"Arntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"key":"4248_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1192\/bjp.2018.202","volume":"213","author":"J Volkert","year":"2018","unstructured":"Volkert J, Gablonski T-C, Rabung S. Prevalence of personality disorders in the general adult population in Western countries: systematic review and meta-analysis. Br J Psychiatry. 2018;213:709\u201315.","journal-title":"Br J Psychiatry"},{"key":"4248_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1192\/bjp.2019.166","volume":"216","author":"C Winsper","year":"2020","unstructured":"Winsper C, Bilgin A, Thompson A, Marwaha S, Chanen AM, Singh SP, et al. The prevalence of personality disorders in the community: a global systematic review and meta-analysis. Br J Psychiatry. 2020;216:69\u201378.","journal-title":"Br J Psychiatry"},{"key":"4248_CR3","first-page":"186","volume-title":"The Oxford Handbook of Personality Disorders","author":"TS Epidemiology","year":"2012","unstructured":"Epidemiology TS. In: Widiger T, editor. The Oxford Handbook of Personality Disorders: Oxford University Press; 2012. p. 186\u2013205."},{"key":"4248_CR4","first-page":"306","volume":"60","author":"J Hutsebaut","year":"2018","unstructured":"Hutsebaut J, Willemsen EMC, Van HL. Time for cluster C personality disorders: state of the art. Tijdschr Psychiatr. 2018;60:306\u201314.","journal-title":"Tijdschr Psychiatr"},{"key":"4248_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1521\/pedi.2006.20.5.510","volume":"20","author":"H Chen","year":"2006","unstructured":"Chen H, Cohen P, Crawford TN, Kasen S, Johnson JG, Berenson K. Relative impact of young adult personality disorders on subsequent quality of life: Findings of a community-based longitudinal study. J Pers Disord. 2006;20:510\u201323.","journal-title":"J Pers Disord"},{"key":"4248_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1192\/bjp.188.5.423","volume":"188","author":"J Coid","year":"2006","unstructured":"Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006;188:423\u201331.","journal-title":"Br J Psychiatry"},{"key":"4248_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1192\/bjp.180.6.536","volume":"180","author":"J Samuels","year":"2002","unstructured":"Samuels J, Eaton WW, Bienvenu OJ, Brown CH, Costa PT, Nestadt G. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002;180:536\u201342.","journal-title":"Br J Psychiatry"},{"key":"4248_CR8","doi-asserted-by":"crossref","unstructured":"Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJ. The economic burden of personality disorders in mental health care. Journal of Clinical Psychiatry, 69(2), 259. Journal of Clinical Psychiatry. 2008;69:259\u201365.","DOI":"10.4088\/JCP.v69n0212"},{"key":"4248_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.comppsych.2011.10.007","volume":"53","author":"I Olss\u00f8n","year":"2012","unstructured":"Olss\u00f8n I, Dahl AA. Avoidant personality problems\u2014their association with somatic and mental health, lifestyle, and social network. A community-based study. Compr Psychiatry. 2012;53:813\u201321.","journal-title":"Compr Psychiatry"},{"key":"4248_CR10","doi-asserted-by":"publisher","first-page":"e1432","DOI":"10.4088\/JCP.14m09412","volume":"76","author":"LLM Bamelis","year":"2015","unstructured":"Bamelis LLM, Arntz A, Wetzelaer P, Verdoorn R, Evers SMAA. Economic evaluation of schema therapy and clarification-Ooriented psychotherapy for personality disorders. J Clin Psychiatry. 2015;76:e1432\u201340.","journal-title":"J Clin Psychiatry"},{"key":"4248_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jclp.23118","volume":"77","author":"N Bachrach","year":"2021","unstructured":"Bachrach N, Arntz A. Group schema therapy for patients with cluster-C personality disorders: A case study on avoidant personality disorder. J Clin Psychol. 2021;77:1233\u201348.","journal-title":"J Clin Psychol"},{"key":"4248_CR12","first-page":"305","volume":"171","author":"LLM Bamelis","year":"2014","unstructured":"Bamelis LLM, Evers SMAA, Spinhoven P, Arntz A. Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders. J Psychiatry. 2014;171:305\u201322.","journal-title":"J Psychiatry"},{"key":"4248_CR13","volume-title":"Schema Therapy: a practitioner\u2019s guide","author":"JE Young","year":"2003","unstructured":"Young JE, Klosko JS, Weishaar ME. Schema Therapy: a practitioner\u2019s guide. New York: The Guilford; 2003."},{"key":"4248_CR14","volume-title":"Cognitive therapy for personality disorders: A schematic-focused approach","author":"JE Young","year":"1990","unstructured":"Young JE. Cognitive therapy for personality disorders: A schematic-focused approach. Sarasota: Professional Resource Exchange; 1990."},{"key":"4248_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/9781119962830.ch30","volume-title":"The Wiley-Blackwell handbook of schema therapy: theory, research and practice","author":"A Arntz","year":"2012","unstructured":"Arntz A. Schema therapy for cluster-C personality disorders. In: Vreeswijk M, Broersen J, Nadort M, editors. The Wiley-Blackwell handbook of schema therapy: theory, research and practice. Chichester: Wiley-Blackwell; 2012. p. 397\u2013414."},{"key":"4248_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1521\/ijct.2013.6.2.171","volume":"6","author":"GA Jacob","year":"2013","unstructured":"Jacob GA, Arntz A. Schema therapy for personality disorders\u2014A review. Int J Cogn Ther. 2013;6:171\u201385.","journal-title":"Int J Cogn Ther"},{"key":"4248_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jbtep.2009.01.002","volume":"40","author":"JM Farrell","year":"2009","unstructured":"Farrell JM, Shaw IA, Webber MA. A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: A randomized controlled trial. J Behav Ther Exp Psychiatry. 2009;40:317\u201328.","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"4248_CR18","doi-asserted-by":"crossref","unstructured":"Fassbinder E, Schuetze M, Kranich A, Sipos V, Hohagen F, Shaw I, et al. Feasibility of group schema therapy for outpatients with severe borderline personality disorder in Germany: A pilot study with three year follow-up. Front Psychol. 2016;7.","DOI":"10.3389\/fpsyg.2016.01851"},{"issue":"4","key":"4248_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamapsychiatry.2022.0010","volume":"79","author":"A Arntz","year":"2022","unstructured":"Arntz A, Jacob GA, Lee CW, Brand-De Wilde OM, Fassbinder E, Harper RP, et al. Effectiveness of predominantly group schema therapy and combined individual and group schema therapy for borderline personality disorder: A randomized clinical trial. JAMA Psychiat. 2022;79(4):287.","journal-title":"JAMA Psychiat"},{"key":"4248_CR20","volume-title":"Group Schema Therapy for Borderline PD. Report to ZONMW","author":"A Arntz","year":"2017","unstructured":"Arntz A. Group Schema Therapy for Borderline PD. Report to ZONMW: University of Amsterdam; 2017."},{"key":"4248_CR21","doi-asserted-by":"crossref","unstructured":"Skewes SA, Samson RA, Simpson SG, van Vreeswijk M. Short-term group schema therapy for mixed personality disorders: a pilot study. Front Psychol. 2015;5.","DOI":"10.3389\/fpsyg.2014.01592"},{"key":"4248_CR22","doi-asserted-by":"crossref","unstructured":"MIND. MIND kennisagenda [Internet]. Homepage. 2017 [cited 2022Jun28]. Available from: https:\/\/mindplatform.nl\/nieuws\/mind-kennisagenda-top-10-onderzoeksprioriteiten-vastgesteld. Accessed\u00a028 June 2022.","DOI":"10.1038\/scientificamericanmind0317-10b"},{"key":"4248_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nlm.2015.01.004","volume":"122","author":"N Landmann","year":"2015","unstructured":"Landmann N, Kuhn M, Maier J-G, Spiegelhalder K, Baglioni C, Frase L, et al. REM sleep and memory reorganization: Potential relevance for psychiatry and psychotherapy. Neurobiol Learn Mem. 2015;122:28\u201340.","journal-title":"Neurobiol Learn Mem"},{"key":"4248_CR24","doi-asserted-by":"crossref","unstructured":"Bamelis LL, Evers SM, Arntz A. Design of a multicentered randomized controlled trial on the clinical and cost effectiveness of schema therapy for personality disorders. BMC Public Health. 2012;12.","DOI":"10.1186\/1471-2458-12-75"},{"key":"4248_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1017\/S1352465816000357","volume":"45","author":"N de Klerk","year":"2017","unstructured":"de Klerk N, Abma TA, Bamelis LL, Arntz A. Schema therapy for personality disorders: A qualitative study of patients\u2019 and therapists\u2019 perspectives. Behav Cogn Psychother. 2017;45:31\u201345.","journal-title":"Behav Cogn Psychother"},{"key":"4248_CR26","volume-title":"Nederlandse vertaling van Structured Clinical Interview for DSM-5\u00ae Personality Disorders (SCID-5-PD)","author":"American Psychiatric Association","year":"2017","unstructured":"American Psychiatric Association. SCID-5-P Gestructureerd klinisch interview voor DSM-5 Persoonlijkheidsstoornissen. In:  Nederlandse vertaling van Structured Clinical Interview for DSM-5\u00ae Personality Disorders (SCID-5-PD). Amsterdam: Boom; 2017."},{"key":"4248_CR27","doi-asserted-by":"crossref","unstructured":"Arntz A, Jacob GA, Lee CW, Brand-de Wilde OM, Fassbinder E, Harper RP, et al. Effectiveness of predominantly group schema therapy and combined individual schema therapy for borderline personality disorder, a randomized clinical trial. JAMA Psychiatry. 2022;79:287-99.","DOI":"10.1001\/jamapsychiatry.2022.0010"},{"key":"4248_CR28","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1176\/appi.ajp.161.5.810","volume":"161","author":"M Svartberg","year":"2004","unstructured":"Svartberg M, Stiles TC, Seltzer MH. Randomized, Controlled Trial of the Effectiveness of Short-Term Dynamic Psychotherapy and Cognitive Therapy for Cluster C Personality Disorders. Am J Psychiatry. 2004;161:810\u20137.","journal-title":"Am J Psychiatry"},{"key":"4248_CR29","unstructured":"Tjoa EEML, Muste EH. Handleiding groepschematherapie cluster C-persoonlijkheidsstoornissen. Bohn Staleu van Loghum; 2021."},{"key":"4248_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/9781118510018","volume-title":"The schema therapy clinician\u2019s guide","author":"JM Farrell","year":"2014","unstructured":"Farrell JM, Reiss N, Shaw IA. The schema therapy clinician\u2019s guide. Hoboken: Wiley-Blackwell; 2014."},{"key":"4248_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s13063-016-1605-9","volume":"17","author":"A Balj\u00e9","year":"2016","unstructured":"Balj\u00e9 A, Greeven A, van Giezen A, Korrelboom K, Arntz A, Spinhoven P. Group schema therapy versus group cognitive behavioral therapy for social anxiety disorder with comorbid avoidant personality disorder: study protocol for a randomized controlled trial. Trials. 2016;17:487.","journal-title":"Trials."},{"key":"4248_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-313-9865-2","volume-title":"Kortdurende schemagroepstherapie: Cognitief gedragstherapeutische technieken","author":"MF van Vreeswijk","year":"2013","unstructured":"van Vreeswijk MF, Broersen J. Kortdurende schemagroepstherapie: Cognitief gedragstherapeutische technieken. 2nd ed. Houten: Bohn Stafleu van Loghum; 2013.","edition":"2"},{"key":"4248_CR33","unstructured":"Balj\u00e9 A et al. Psychometric properties of the AVPDSI (Unpublished manuscript)."},{"key":"4248_CR34","unstructured":"Tese S. Psychometric evaluation of the DPDSI. Thesis RINO Groep 2019."},{"key":"4248_CR35","unstructured":"Verheul H. Psychometric evaluation of the OCPDSI. Thesis RINO Groep. 2020."},{"key":"4248_CR36","volume-title":"The personality disorder beliefs questionnaire (short version)","author":"L Dreessen","year":"1995","unstructured":"Dreessen L, Arntz A. The personality disorder beliefs questionnaire (short version). Maastricht: author; 1995."},{"key":"4248_CR37","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.brat.2003.08.004","volume":"42","author":"A Arntz","year":"2004","unstructured":"Arntz A, Dreessen L, Schouten E, Weertman A. Beliefs in personality disorders: a test with the Personality Disorder Belief Questionnaire. Behav Res Ther. 2004;42:1215\u201325.","journal-title":"Behav Res Ther"},{"key":"4248_CR38","doi-asserted-by":"crossref","unstructured":"Rosenberg M. Society and the adolescent self-image. NJ. 1965.","DOI":"10.1515\/9781400876136"},{"key":"4248_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5334\/pb-48-1-25","volume":"48","author":"E Franck","year":"2008","unstructured":"Franck E, de Raedt R, Barbez C, Rosseel Y. Psychometric properties of the Dutch Rosenberg self-esteem scale. Psychol Belg. 2008;48:25\u201335.","journal-title":"Psychol Belg"},{"key":"4248_CR40","volume-title":"Description of the self","author":"RW Miskimins","year":"1971","unstructured":"Miskimins RW, Braucht GN. Description of the self: Rocky Mountain Behavioral Science Institute; 1971."},{"key":"4248_CR41","doi-asserted-by":"crossref","unstructured":"Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13.","DOI":"10.1017\/S0033291700048017"},{"key":"4248_CR42","first-page":"120","volume":"61","author":"E de Beurs","year":"2006","unstructured":"de Beurs E, Zitman FG. De Brief Symptom Inventory (BSI): The reliability and validity of a brief alternative of the SCL-90. Maandblad Geestelijke Volksgezondheid. 2006;61:120\u201337.","journal-title":"Maandblad Geestelijke Volksgezondheid"},{"key":"4248_CR43","unstructured":"World Health Organization. World Health Organization disability assessment schedule WHODAS II. Geneva: World Health Organization; 2000."},{"key":"4248_CR44","volume-title":"Measuring health and disability: Manual for WHO disability assessment schedule WHODAS 2.0","author":"T \u00dcst\u00fcn","year":"2010","unstructured":"\u00dcst\u00fcn T, Kostanjsek N, Chatterji S, Rehm J. Measuring health and disability: Manual for WHO disability assessment schedule WHODAS 2.0. Geneva: World Health Organizaition; 2010."},{"key":"4248_CR45","doi-asserted-by":"crossref","unstructured":"van Krugten FCW, Busschbach JJ, Versteegh MM, Hakkaart-van Roijen L, WBF B. The Mental Health Quality of Life Questionnaire (MHQoL): development and first psychometric evaluation of a new measure to assess quality of life in people with mental health problems. Qual Life Res. 2021;31:633-43.","DOI":"10.1007\/s11136-021-02935-w"},{"key":"4248_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol group","year":"1990","unstructured":"The EuroQol group. EuroQol-a new faciliEuroQol-a new facility for the measurement of health-related quality of lifety for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"4248_CR47","doi-asserted-by":"crossref","unstructured":"Long D, Polinder S, Bonsel J, Haagsma JA. Test\u2013retest reliability of the EQ-5D-5L and the reworded QOLIBRI-OS in the general population of Italy, the Netherlands, and the United Kingdom. Qual Life Res. 2021;30:1\u201311.","DOI":"10.1007\/s11136-021-02893-3"},{"key":"4248_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2224\/sbp.2006.34.2.139","volume":"34","author":"AM Abdel-Khalek","year":"2006","unstructured":"Abdel-Khalek AM. Measuring happiness with a single-item scale. Soc Behav Personal Int J. 2006;34:139\u201350.","journal-title":"Soc Behav Personal Int J"},{"key":"4248_CR49","volume-title":"Young schema questionnaire short form","author":"JE Young","year":"1998","unstructured":"Young JE, Brown G. Young schema questionnaire short form. New York: Cognitive Therapy Centre; 1998."},{"key":"4248_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jad.2006.03.003","volume":"93","author":"J Baranoff","year":"2006","unstructured":"Baranoff J, Oei TPS, Cho SH, Kwon S-M. Factor structure and internal consistency of the Young Schema Questionnaire (Short Form) in Korean and Australian samples. J Affect Disord. 2006;93:133\u201340.","journal-title":"J Affect Disord"},{"key":"4248_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1521\/pedi.2011.25.1.41","volume":"25","author":"LLM Bamelis","year":"2011","unstructured":"Bamelis LLM, Renner F, Heidkamp D, Arntz A. Extended Schema Mode Conceptualizations for Specific Personality Disorders: An Empirical Study. J Pers Disord. 2011;25:41\u201358.","journal-title":"J Pers Disord"},{"key":"4248_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1207\/s15402010bsm0304_4","volume":"3","author":"VI Spoormaker","year":"2005","unstructured":"Spoormaker VI, Verbeek I, van den Bout J, Klip EC. Initial validation of the SLEEP-50 questionnaire. Behav Sleep Med. 2005;3:227\u201346.","journal-title":"Behav Sleep Med"},{"key":"4248_CR53","unstructured":"Arntz A, Venhuizen ASSM, Bachrach N, Groot IZ. Introversion Inventory (Unpublished manuscript). University of Amsterdam; 2021."},{"key":"4248_CR54","unstructured":"Hoekstra HA, Ormel J, de Fruyt F. NEO PI-R, NEO-FFI Big Five Persoonlijkheids vragenlijsten: Handleiding. Lisse: Hogrefe; 1996."},{"key":"4248_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1005653411471","volume":"31","author":"S Baron-Cohen","year":"2001","unstructured":"Baron-Cohen S, Sheelwright S, Skinner R, Martin CE. The Autism Spectrum Quotient (AQ): Evidence from Asperger syndrome\/high functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31:5\u201317.","journal-title":"J Autism Dev Disord"},{"key":"4248_CR56","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s10803-013-1844-5","volume":"43","author":"T Booth","year":"2013","unstructured":"Booth T, Murray AL, McKenzie K, Kuenssberg R, O\u2019Donnell M, Burnett H. Brief report: An evaluation of the AQ-10 as a brief screening instrument for ASD in adults. J Autism Dev Disord. 2013;43:2997\u20133000.","journal-title":"J Autism Dev Disord"},{"key":"4248_CR57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jaac.2011.11.003","volume":"51","author":"C Allison","year":"2012","unstructured":"Allison C, Auyeung B, Baron-Cohen S. Toward brief \u201cRed Flags\u201d for autism screening: The short Autism Spectrum Quotient and the Short Quantitative Checklist in 1,000 cases and 3,000 controls. J Am Acad Child Adolesc Psychiatry. 2012;51:202\u2013212.e7.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4248_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0145-2134(02)00541-0","volume":"27","author":"DP Bernstein","year":"2003","unstructured":"Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003;27:169\u201390.","journal-title":"Child Abuse Negl"},{"key":"4248_CR59","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.chiabu.2009.03.001","volume":"33","author":"BD Thombs","year":"2009","unstructured":"Thombs BD, Bernstein DP, Lobbestael J, Arntz A. A validation study of the Dutch Childhood Trauma Questionnaire-Short Form: Factor structure, reliability, and known-groups validity. Child Abuse Negl. 2009;33:518\u201323.","journal-title":"Child Abuse Negl"},{"key":"4248_CR60","first-page":"15","volume":"22","author":"B Schmand","year":"1991","unstructured":"Schmand B, Bakker D, Saan R, Louman J. De Nederlandse Leestest voor Volwassenen: een maat voor het premorbide intelligentieniveau. Gerontologie en Geriatrie. 1991;22:15\u20139.","journal-title":"Gerontologie en Geriatrie"},{"key":"4248_CR61","doi-asserted-by":"publisher","first-page":"e83875","DOI":"10.1371\/journal.pone.0083875","volume":"9","author":"RJ DeRubeis","year":"2014","unstructured":"DeRubeis RJ, Cohen ZD, Forand NR, Fournier JC, Gelfand LA, Lorenzo-Luaces L. The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration. PLoS One. 2014;9:e83875.","journal-title":"PLoS One"},{"key":"4248_CR62","doi-asserted-by":"publisher","first-page":"e0140771","DOI":"10.1371\/journal.pone.0140771","volume":"10","author":"MJ Huibers","year":"2015","unstructured":"Huibers MJ, Cohen ZD, Lemmens LH, Arntz A, Peeters FP, Cuijpers P, et al. Predicting optimal outcomes in cognitive therapy or interpersonal psychotherapy for depressed individuals using the personalized advantage index approach. PLoS One. 2015;10:e0140771.","journal-title":"PLoS One"},{"key":"4248_CR63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","volume":"19","author":"MM Versteegh","year":"2016","unstructured":"Versteegh MM, Vermeulen KM, Evers SM, De Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level Version of EQ-5D. Value Health. 2016;19:343\u201352.","journal-title":"Value Health"},{"key":"4248_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-13-217","volume":"13","author":"C Bouwmans","year":"2013","unstructured":"Bouwmans C, de Jong K, Timman R, Zijlstra-Vlasveld M, van der Feltz-Cornelis C, Tan SS. Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P). BMC Health Serv Res. 2013;13:1\u20139.","journal-title":"BMC Health Serv Res"},{"key":"4248_CR65","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes: Oxford university press; 2015."},{"key":"4248_CR66","unstructured":"Hakkaart-van Roijen L, van der Lindern N, Bouwmans C, Kanters T, Swan Tan S. Kostenhandleiding. 2016."},{"key":"4248_CR67","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1177\/0272989X13482045","volume":"33","author":"MRC Hendriks","year":"2013","unstructured":"Hendriks MRC, Al MJ, Bleijlevens MHC, van Haastregt JCM, Crebolder HFJM, van Eijk JTM, et al. Continuous versus intermittent data collection of health care utilization. Med Decis Making. 2013;33:998\u20131008.","journal-title":"Med Decis Making"},{"key":"4248_CR68","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.944","volume":"14","author":"A Manca","year":"2005","unstructured":"Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14:487\u201396.","journal-title":"Health Econ"},{"key":"4248_CR69","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W","volume":"6","author":"AH Briggs","year":"1997","unstructured":"Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6:327\u201340.","journal-title":"Health Econ"},{"key":"4248_CR70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"4248_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/0147-1767(85)90062-8","volume-title":"Naturalistic inquiry","author":"YS Lincoln","year":"1985","unstructured":"Lincoln YS, Guba EG. Naturalistic inquiry. Beverly Hills: SAGE; 1985."},{"key":"4248_CR72","doi-asserted-by":"publisher","DOI":"10.4135\/9781529682571","volume-title":"Qualitative content analysis in practice","author":"M Schreier","year":"2012","unstructured":"Schreier M. Qualitative content analysis in practice. Thousand Oaks: SAGE; 2012."},{"key":"4248_CR73","volume-title":"The Sage handbook of qualitative data collection","author":"M Schreier","year":"2018","unstructured":"Schreier M. The Sage handbook of qualitative data collection. Londen: SAGE; 2018."},{"key":"4248_CR74","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1017\/S1352465817000741","volume":"46","author":"E Bastick","year":"2018","unstructured":"Bastick E, Bot S, Verhagen SJW, Zarbock G, Farrell J, Brand-De Wilde O, et al. The development and psychometric evaluation of the Group Schema Therapy Rating Scale-Revised. Behav Cogn Psychother. 2018;46:601\u201318.","journal-title":"Behav Cogn Psychother"}],"updated-by":[{"DOI":"10.1186\/s12888-024-06431-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000}}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04248-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04248-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04248-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T13:02:10Z","timestamp":1735650130000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04248-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4248"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04248-9","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12888-024-06431-6","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12888-024-06431-6","URL":"https:\/\/doi.org\/10.1186\/s12888-024-06431-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study protocol is approved by the local ethical committee of the department of Psychology of the University of Amsterdam (2020-CP-12948). Written informed consent will be obtained from the participants, fully informing them of the aims and procedures of the study, and asking permission for further use of the data, pseudonymized (see Appendix ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"637"}}